A new study published in August of 2013 in the Journal of Neuroscience unveiled the latest in neurogenic disease research. This study, lead by Alexander Stephan, PhD of Stanford University’s School of Medicine, investigated proteins in the brain collected over the lifespan, and whether these proteins were related to neurogenic diseases such as Alzheimers, Parkinson’s, and Multiple Sclerosis.
After examining mouse and human brain tissue across a range of ages, they discovered as much as a 300-fold age-related build-up of a protein called C1q. This protein is a well-known key initiator of the body’s immune response, and an elevated concentration at the brain’s synapses can lead to catastrophic destruction by brain-dwelling immune cells. Click here to continue reading what their study discovered and how it will effect neurogenic treatment and research going forward!
Image courtesy of webmd.com